Clinical Microbiology and Infection

Article	Citations
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis	983
COVID-19, SARS and MERS: are they closely related?	756
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study	572
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	546
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis	496
Follow-up of adults with noncritical COVID-19 two months after symptom onset	488
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting	464
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study	455
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China	428
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay	415
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society	329
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19	281
Novel SARS-CoV-2 variants: the pandemics within the pandemic	269
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis	262
COVID-19 pandemic—a focused review for clinicians	259
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis	248
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel	246
COVID-19: don't neglect antimicrobial stewardship principles!	245
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults	241
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study	234
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India	228
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors	219
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain	217
Female gender is associated with long COVID syndrome: a prospective cohort study	216
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications	214

Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis	204
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres	203
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients	201
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	191
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis	190
Viable SARS-CoV-2 in various specimens from COVID-19 patients	177
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study	166
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study	165
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans	160
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital	155
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection	147
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study	142
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis	138
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline	137
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection	132
Validation of a commercially available SARS-CoV-2 serological immunoassay	131
Pathogenesis and management of fracture-related infection	130
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity	126
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results	126
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1	121
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology	119
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review	117
Post–COVID-19 chronic symptoms: a postinfectious entity?	117
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico	115
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit	115
2020 list of human papillomavirus assays suitable for primary cervical cancer screening	115
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs	115
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)	113
Anosmia in COVID-19 patients	112
Ibuprofen use and clinical outcomes in COVID-19 patients	102
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients	102
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review	101
Understanding the role of bacterial and fungal infection in COVID-19	101
ESCMID COVID-19 living guidelines: drug treatment and clinical management	99
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage	99
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients	98
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities	98
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study	95
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review	94
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan	93
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status	92
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort	92
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study	92
Stigma at the time of the COVID-19 pandemic	91
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study	91
Association of COVID-19 with pregnancy outcomes in health-care workers and general women	91
The interface between COVID-19 and bacterial healthcare-associated infections	90
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection	90
How to interpret and use COVID-19 serology and immunology tests	89
Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis	88

Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study	88
Clostridium difficile and One Health	87
Current landscape in the discovery of novel antibacterial agents	86
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study	85
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort	85
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy	84
Evolution of viral quasispecies during SARS-CoV-2 infection	83
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients	83
Commercially available molecular tests for human papillomaviruses: a global overview	83
Pulmonary long-term consequences of COVID-19 infections after hospital discharge	82
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review	82
Neurologic manifestations associated with COVID-19: a multicentre registry	82
Risk factors for chronic biofilm-related infection associated with implanted medical devices	80
Follow-up of asymptomatic patients with SARS-CoV-2 infection	80
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy	79
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)	78
How do I manage nocardiosis?	77
Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre	77
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns	75
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19	73
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy	73
Review of trials currently testing treatment and prevention of COVID-19	73
Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea	71
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis	71
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	71
Use of drones in clinical microbiology and infectious diseases: current status, challenges and barriers	70
Excretion of SARS-CoV-2 in human breast milk	70
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients	68
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples	66
New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection	66
ESCMID rapid guidelines for assessment and management of long COVID	66
Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection	65
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review	65
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?	63
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review	63
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks	62
Machine learning in infection management using routine electronic health records: tools, techniques, and reporting of future technologies	61
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients	61
Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital	60
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial	60
Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves	60
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation	59
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)	58
Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship	58
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial	58
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis	58
Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine	57
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization	56
Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort	56
Corticosteroid administration for viral pneumonia: COVID-19 and beyond	54
Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability	54
Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect	54
Long COVID-19—it's not over until?	53
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis	53
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del)	52
Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2	52
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study	52
Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications	52
SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy	52
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	52
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses	51
CT lung lesions as predictors of early death or ICU admission in COVID-19 patients	51
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins	51
Long-term persistence of olfactory and gustatory disorders in COVID-19 patients	50
Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19	50
Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis	50
Serology anno 2021—fungal infections: from invasive to chronic	50
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study	50
Culture-independent detection systems for bloodstream infection	49
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)	49
Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking	49
Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis	49
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates – the EUCAST broth microdilution reference method for MIC determination	49
High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum	49
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton	49
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis	48
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19	48
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay	48
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery	48
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019	47

Socioeconomic disparities and COVID-19 vaccination acceptance: a nationwide ecologic study	47
Novel coronavirus: how things are in Wuhan	47
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis	47
Invasive aspergillosis in patients with severe COVID-19 pneumonia	46
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19	45
Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study	45
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting	45
Update on SARS-CoV-2 seroprevalence: regional and worldwide	45
Detection of multiple hypervirulent Klebsiella pneumoniae strains in a New York City hospital through screening of virulence genes	44
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes	44
Antibiotic use in the COVID-19 crisis in Spain	44
The kinetics of viral load and antibodies to SARS-CoV-2	44
Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis	44
Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system	42
Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study	42
Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial	42
Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence	42
Co-infection with other respiratory pathogens in COVID-19 patients	41
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives	41
Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA	41
Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study	41
Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression	41
Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia	41
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data	41
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review	40
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis	40
Lower respiratory tract infection in the community: associations between viral aetiology and illness course	40
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community	40
How to start an antimicrobial stewardship programme in a hospital	40
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae	38
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	38
Image analysis and artificial intelligence in infectious disease diagnostics	38
Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia	38
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study	38
Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study	38
Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study	38
Saliva for molecular detection of SARS-CoV-2 in school-age children	38
Multistate population and whole genome sequence-based strain surveillance of invasive pneumococci recovered in the USA during 2017	37
Smartphones as mobile microbiological laboratories	37
Quantifying the transmission of antimicrobial resistance at the human and livestock interface with genomics	37
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis	36
The WHO essential medicines list AWaRe book: from a list to a quality improvement system	36
Microbiology of hip and knee periprosthetic joint infections: a database study	36
Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 ‘superplasmids’ in clinical carbapenem-resistant Enterobacterales	36
Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing	36
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)	36
SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay	36
Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity	36
Personal protective equipment protecting healthcare workers in the Chinese epicentre of COVID-19	35
Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis	35
Probiotics for intestinal decolonization of ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled clinical trial	35
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance	35
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper	35
Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection	35
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations	35
The recent emergence of a highly related virulent Clostridium difficile clade with unique characteristics	35
Invasive infections with Fusobacterium necrophorum including Lemierre's syndrome: an 8-year Swedish nationwide retrospective study	34
Assessment of prevalence and load of torquetenovirus viraemia in a large cohort of healthy blood donors	34
Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study	33
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort	33
Dynamics and predisposition of respiratory viral co-infections in children and adults	33
Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales	33
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort	33
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?	33
An update on Toscana virus distribution, genetics, medical and diagnostic aspects	33
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study	33
Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance	33
Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae	32
Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial	32
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis	32
Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2	32
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain	32
Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain	32
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	31
The impact of COVID-19 on community antibiotic use in Canada: an ecological study	31
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19	31
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	31
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations	31
Pretomanid for tuberculosis: a systematic review	31
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020—a cross-sectional study	31
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?	31
Dramatically improved hand hygiene performance rates at time of coronavirus pandemic	31
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients	31
Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation	31
National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave	30
Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey	30
Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vac	30
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study	30
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects	30
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage	30
How do I manage a patient with enterococcal bacteraemia?	30
Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries	30
In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris	30
Aminoglycosides for infective endocarditis: time to say goodbye?	30
Sample pooling for SARS-CoV-2 RT-PCR screening	30